APRelated
Related Companies
NSE
BSE
NEW DELHI: Country’s biggest institutional investors Life Insurance Corporation of India and ace equity investor Rakesh Jhunjhunwala lapped up additional shares in pharmaceutical firm Lupin during the July-September quarter.
The latest shareholding data revealed that Jhunjhunwala held 69,45,605 shares, or 1.53 per cent stake, in the company as of September 30 against 66,45,605 shares or 1.47 per cent stake owned by him in the June quarter.
On the other hand, LIC’s stake increased to 3.71 per cent from 2.70 per cent during the same period.
Shares of the company traded 2.33 per cent down at Rs 1,032 at around 2.15 pm (IST) on Wednesday, while the benchmark BSE Sensex traded 0.49 per cent lower at 40,426.
Total holdings of mutual fund houses in the company also increased to 12.58 per cent from 11.94 per cent on a quarter-on-quarter basis, data available with BSE showed on Tuesday.
On a year-to-date basis, Lupin shares have gained 38 per cent while Sensex has retreated 1.52 per cent.
Brokerage firm Prabhudas Lilladher is positive on the stock with a target price of Rs 1,085.
“We remain upbeat of Lupin on regulatory revival theme and new launches in the US market,” the brokerage said.
In the recent update, Lupin last week said it has received approval from the US health regulator to market generic Dimethyl Fumarate delayed-release capsules used for the treatment of relapsing forms of multiple sclerosis in adults.
The company has received approval from the United States Food and Drug Administration (USFDA) to market its Dimethyl Fumarate delayed-release capsules in the strengths of 120 mg and 240 mg, Lupin said in a statement.
Overall, analysts are positive on the pharmaceutical sector due to steady earnings visibility going ahead.
According to ICICI Prudential AMC, pharma sector may do well due to its critical nature post Covid-19. “Earnings visibility is high and the sector is also a good defensive play in times of volatility,” the mutual fund house said.
The latest shareholding data revealed that Jhunjhunwala held 69,45,605 shares, or 1.53 per cent stake, in the company as of September 30 against 66,45,605 shares or 1.47 per cent stake owned by him in the June quarter.
On the other hand, LIC’s stake increased to 3.71 per cent from 2.70 per cent during the same period.
Shares of the company traded 2.33 per cent down at Rs 1,032 at around 2.15 pm (IST) on Wednesday, while the benchmark BSE Sensex traded 0.49 per cent lower at 40,426.
Total holdings of mutual fund houses in the company also increased to 12.58 per cent from 11.94 per cent on a quarter-on-quarter basis, data available with BSE showed on Tuesday.
On a year-to-date basis, Lupin shares have gained 38 per cent while Sensex has retreated 1.52 per cent.
Brokerage firm Prabhudas Lilladher is positive on the stock with a target price of Rs 1,085.
“We remain upbeat of Lupin on regulatory revival theme and new launches in the US market,” the brokerage said.
In the recent update, Lupin last week said it has received approval from the US health regulator to market generic Dimethyl Fumarate delayed-release capsules used for the treatment of relapsing forms of multiple sclerosis in adults.
The company has received approval from the United States Food and Drug Administration (USFDA) to market its Dimethyl Fumarate delayed-release capsules in the strengths of 120 mg and 240 mg, Lupin said in a statement.
Overall, analysts are positive on the pharmaceutical sector due to steady earnings visibility going ahead.
According to ICICI Prudential AMC, pharma sector may do well due to its critical nature post Covid-19. “Earnings visibility is high and the sector is also a good defensive play in times of volatility,” the mutual fund house said.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Also Read
Rakesh Jhunjhunwala reveals his pearls of wisdom, asks Robinhoods to stop trading- Rakesh Jhunjhunwala reveals stocks & sectors he likes most
- Despite strong rural economy traction, Rakesh Jhunjhunwala cuts stake in Escorts
- Rakesh Jhunjhunwala picked up these battered stocks all through June quarter
- Rakesh Jhunjhunwala laps up Indian Hotels, Federal Bank in Q1
- Rakesh Jhunjhunwala hikes stake in this BPO firm, shares rally
3 Comments on this Story
 | Suresh Kamath29 minutes ago RJ and his tactics to simulate interest in this Counter and RJ NEED NOT be followed as a "WARREN BUFFET" as he never discloses the Investment which benefit others BUT self Interest and has made MILLIONS but his plan PROJECT to DONATE his WEALTH seems to have hit a WALL and SILENT on this |
 | RajeshK41 minutes ago The Psychology of Money https://amzn.to/317sAG5 |
| Akshaya 1 hour ago This is a very slow counter since long...Now we could see some upmove... good time to enter |
